Wikisage, the free encyclopedia of the second generation, is digital heritage

Epilepsy: Difference between revisions

From Wikisage
Jump to navigation Jump to search
(world health Org)
Line 55: Line 55:


<ref>http://www.who.int/mediacentre/factsheets/fs999/en/</ref>
<ref>http://www.who.int/mediacentre/factsheets/fs999/en/</ref>
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325583/pdf/i1535-7511-14-6-339.pdf epilepsy is not resolved. Epilepsy Currents 14 2014]</ref>
<ref>https://www.ligaepilepsia.cl/epilepsias/tipos-de-epilepsia</ref>
<ref>https://www.ligaepilepsia.cl/epilepsias/tipos-de-epilepsia</ref>
[http://www.ilae.org/Visitors/Publications/documents/ED_Arzimanoglou_2013.pdf A new perspective for Epileptic Disorders]
[http://www.ilae.org/Visitors/Publications/documents/ED_Arzimanoglou_2013.pdf A new perspective for Epileptic Disorders]

Revision as of 17:21, 25 July 2015

Classification of ethiology could divided in four categories:

  • idiopathic epilepsy
  • symptomatic epilepsy
  • provoked epilepsy
  • cryptogenic epilepsy

[1] It is difficult to distinguish between genetic and cryptogenic syndromes.

Morbility data is difficult to interpret when WHO[2] states 50 millions persons affect by epilepsy[3]

nonadherence appears to be associated with increased health care costs,nevertheless XR-medicine appears as strategy to overcome compliance wih AED[4]

Medicines

type  ,,, ,,,,
INN  Generic slow release
carbamazepine  normal xr
lamotrigine  normal xr
levetiracetam  normal xr
oxcarbazepine  ... xr
phenitoin  ... xr
valproate  xr
topiramat  xr

AED

ILAE Classification

[5] [6] [7] A new perspective for Epileptic Disorders

Links

Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population Dravet's syndrome


References

References: